Back to results
US 2004/0166119 A1Published application
Prevention and treatment of amyloidogenic disease
AssigneeNeuralab Limited
InventorDale B. Schenk
Life of this patent
Estimating the term…
Abstract
The invention provides compositions and methods for treatment of amyloidogenic diseases. Such methods entail administering an agent that induces a beneficial immune response against an amyloid deposit in the patient. The methods are particularly useful for prophylactic and therapeutic treatment of Alzheimer's disease. In such methods, a suitable agent is Aβ peptide or an antibody thereto.
Claims38
A pharmaceutical composition comprising an Aβ peptide and a pharmaceutically acceptable adjuvant effective to induce an immune response comprising antibodies to Aβ in a patient, wherein the adjuvant enhances the immune response to Aβ.
Dependencies are inferred from the claim text.